ArticleBMC women's health2024

Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of Ki-67, CDK4, EGFR, TILs and ctDNA.

Tianzhao Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.